| 000 | 01360 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513155341.0 | ||
| 264 | 0 | _c19990318 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0083-8969 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBenquet, C | |
| 245 | 0 | 0 |
_aLipid A-induced oxidative stress requires protein tyrosine kinases and protein kinase C activation, but not intracellular calcium mobilization in human polymorphonuclear leukocytes. _h[electronic resource] |
| 260 |
_bProceedings of the Western Pharmacology Society _c1998 |
||
| 300 |
_a207-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aLipid A _xadverse effects |
| 650 | 0 | 4 |
_aNeutrophils _xmetabolism |
| 650 | 0 | 4 |
_aOxidative Stress _xphysiology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aStaurosporine _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKouassi, E | |
| 773 | 0 |
_tProceedings of the Western Pharmacology Society _gvol. 41 _gp. 207-10 |
|
| 999 |
_c9800308 _d9800308 |
||